Pulmatrix introduces inhaled dry powder drug delivery platform iSPERSE
The iSPERSE platform enables the delivery of small molecule drugs, drug combinations (including triple drug combinations or higher) and macromolecule drugs at doses well in excess of those
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.